0001104659-21-124842.txt : 20211008
0001104659-21-124842.hdr.sgml : 20211008
20211008215849
ACCESSION NUMBER: 0001104659-21-124842
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211006
FILED AS OF DATE: 20211008
DATE AS OF CHANGE: 20211008
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hubbard John W
CENTRAL INDEX KEY: 0001622323
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39727
FILM NUMBER: 211316529
MAIL ADDRESS:
STREET 1: 101 POOR FARM ROAD 3RD FLOOR
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Science 37 Holdings, Inc.
CENTRAL INDEX KEY: 0001819113
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 844278203
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 600 CORPORATE POINTE
STREET 2: SUITE 320
CITY: CULVER CITY
STATE: CA
ZIP: 90230
BUSINESS PHONE: (984)377-3737
MAIL ADDRESS:
STREET 1: 600 CORPORATE POINTE
STREET 2: SUITE 320
CITY: CULVER CITY
STATE: CA
ZIP: 90230
FORMER COMPANY:
FORMER CONFORMED NAME: Lifesci Acquisition II Corp.
DATE OF NAME CHANGE: 20200723
4
1
tm2129593d16_4.xml
OWNERSHIP DOCUMENT
X0306
4
2021-10-06
0
0001819113
Science 37 Holdings, Inc.
SNCE
0001622323
Hubbard John W
C/O 3411 SILVERSIDE RD, TATNALL BUILDING
#104
WILMINGTON
DE
19810
0
1
0
0
Director
Stock Option
0.28
2021-10-06
4
A
0
403896
A
2030-04-21
Common Stock
403896
403896
D
Pursuant to the business combination of LifeSci Acquisition II Corp and Science 37, Inc. ("Old Science 37"), as contemplated by that certain agreement and plan of merger, dated May 6, 2021 (the "Merger Agreement"), (a) each share of common stock of Old Science 37 outstanding immediately prior to the effective time of the business combination was converted into approximately 1.8153 shares of the Issuer's Common Stock, (b) (the "Conversion Ratio"); and (b) each outstanding stock option of Old Science 37 was converted into a corresponding option to purchase shares of the Issuer's Common Stock as adjusted for the Conversion Ratio
Stock Option is currently vested and exercisable as to 126,217 of the underlying shares, and the remaining shares will vest in equal monthly installments until fully vested on June 15, 2024.
/s/ Christine Pellizzari, Attorney-in-Fact for John W. Hubbard
2021-10-08